Company Filing History:
Years Active: 2016
Title: Hiroyuki Funaoka: Innovator in Nephritis Diagnosis
Introduction: Hiroyuki Funaoka, an accomplished inventor based in Suita, Japan, has made significant contributions to the field of medical diagnostics. He holds a patent that addresses the testing of nephritis-lesion sites, showcasing his innovative approach to healthcare solutions.
Latest Patents: Funaoka's patent, titled "Method for Testing for Nephritis-Lesion Sites and Reagent Therefor," details a method for measuring and comparing multimers of FSP1 and monomers of FSP1. This method utilizes an FSP1-specific antibody, offering a valuable tool for nephritis diagnosis.
Career Highlights: Throughout his career, Hiroyuki Funaoka has held significant positions in reputable organizations. He has collaborated with the National University Corporation University of Fukui, contributing to academic advancements in his field. Additionally, he has worked at Ds Pharma Biomedical Co., Ltd., where he further developed his expertise in biomedical innovations.
Collaborations: Funaoka’s work has included collaboration with notable professionals, including his coworker Masayuki Iwano. Together, they have engaged in research and development efforts that focus on enhancing diagnostic methods in medicine.
Conclusion: Hiroyuki Funaoka stands out as a key figure in the medical innovation landscape, demonstrating a strong commitment to improving diagnostic techniques for nephritis. His patent signifies an important step forward in the field, reflecting both his expertise and dedication to advancing healthcare solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.